Another example is the potential of exosomal protein cargo, macrophage migration inhibitory factor (MIF), to reshape the phenotype of drug-sensitive cancer cells into temozolomide-resistant cells by positively modulating phosphoinositide 3-kinase (PI3K)/AKT signaling. This evidence concerns the gene MIF and cancer.